GNIPST BULLETIN 2015

17-07-2015

17th July, 2015

Volume No.: 47 Issue No.: 02

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE

FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE
BASED LEARNING AND PRACTICE

Contents

Message from PRINCIPAL

Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking
News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive

GNIPST Photo Gallery

For your comments/contribution

OR For Back-Issues,
mailto:gnipstbulletin@gmail.com
GURU NANAK INSTITUTE OF PHARMACEUTICAL
SCIENCE AND TECHNOLOGY
Website: http://gnipst.ac.in

17-07-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.
Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.
I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.
It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.
The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.
The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.
I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.
Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.
My best wishes to all.
Dr. A. Sengupta

Click here to go at the top

1

17-07-2015

EDITORIAL BOARD
CHIEF EDITOR
EDITOR
ASSOCIATE EDITOR

DR. ABHIJIT SENGUPTA

MS. JEENATARA BEGUM
MR. DIPANJAN MANDAL

HISTORICAL ARTICLE

J. Willard Gibbs (1839 1903)

Willard Gibbs was a mathematical physicist who made enormous

contributions to science: he founded modern statistical mechanics,
he founded chemical thermodynamics, and he invented vector
analysis.
Early Life and Education
Josiah Willard Gibbs was born on February 11, 1839 in New Haven,
Connecticut, USA, the hometown of Yale University.
Willard Gibbs family was prosperous and intellectual. His
mothers name was Mary Anna Van Cleve. She came from an
eminent family and was an amateur ornithologist. His fathers
name was also Josiah Willard Gibbs. To avoid confusion, Gibbs Jr.
was always known as Willard. His father, an expert on languages
and linguistics, was a professor of sacred literature at Yale
Universitys School of Divinity.
Willard Gibbs was privately educated at Hopkins Grammar
School until he enrolled at Yale University, aged just 15. He was
awarded his degree four years later, in 1858, along with university
prizes in mathematics and Latin.
He immediately began working for an engineering Ph.D. at Yale,
which he was awarded in 1863, at the age of 24. This was the first
ever award of an engineering Ph.D. to any student at an American
university.
His highly mathematical thesis had the title: On the Forms of the
Teeth of Wheels in Spur Gearing.
Socially, Gibbs was quiet and bookish, a somewhat reserved
student. Academically, he was brilliant.
Click here to go at the top
2

17-07-2015

While Gibbs was a student, three significant events took place:

In 1855, his mother died.
In 1861, his father died, leaving Gibbs and his two sisters a
substantial inheritance, making them financially independent.
From 186165 the American Civil War raged. Gibbs was not
conscripted: his health was fragile, and he suffered from
respiratory problems. Also, his eyesight for reading was blurred,
caused by astigmatism. He eventually had to grind lenses himself
to solve this problem.
Gibbs Academic Career
Tutoring
at
Yale
Yale University appointed Gibbs as a tutor in 1863. Tutors were
expected to make themselves available to teach any of Yales
courses. Gibbs taught Latin for two years, followed by a year
teaching physics, while he continued privately to widen and
sharpen his knowledge of engineering and the physical sciences.
During this time he patented an improved railway car brake.
Three
Years
in
France
and
Germany
In 1866 Gibbs and his sisters, Anna and Julia, set off on a three-year
trip to Europe.
Gibbs spent an academic year at each of the Sorbonne in Paris, and
the Universities of Berlin and Heidelberg in Germany. His singleminded purpose was to continue expanding and refining his
scientific knowledge.
Like his father, he seems to have had a considerable gift for
languages, so working in French and German caused him no
problems.
France, Germany and the United Kingdom lay at the heart of the
scientific world. Gibbs took a unique approach by spending three
years studying in the non-English speaking countries, which gave
him a distinctive scientific viewpoint compared with other
American scientists of the time.
During the trip to Europe, Gibbs health was again a concern
tuberculosis was suspected and he and his sisters moved to the
French Riviera, hoping the warm, dry Mediterranean climate
Click here to go at the top
3

17-07-2015

would help him. Thankfully, after a few months on the Riviera, he

was pronounced free of tuberculosis.
Professorship
at
Yale
On his return to New Haven, Gibbs taught French for a time at
Yale, and worked privately on some of his engineering ideas.
In 1871 he was appointed Yales first professor of mathematical
physics. The role was unpaid. Gibbs was happy with this situation
he was a man of modest needs, and his inheritance provided him
with more than enough money. Furthermore, Gibbs was happy
that the role required little teaching work, allowing him more
thinking and research time.
As his scientific reputation grew, other universities head-hunted
him. Gibbs chose to stay at Yale, because he was happy in the
familiar surroundings of his hometown and, also, Yales other
scientists told him how much they valued his presence at the
university. He stayed at Yale for the whole of his career and the
University started paying him a salary to counterbalance offers he
received from other institutions.
Reshaping the Science of Thermodynamics
In 1878 Gibbs published a third thermodynamics paper, the most
revolutionary of them all. On the Equilibrium of Heterogeneous Substances
Part II.
In this paper Gibbs founded the science of chemical
thermodynamics, entirely shaping our modern understanding of
the field. This work lies at the heart of physical chemistry, telling
us which chemical reactions are feasible.
Unfortunately, Gibbs work was so highly mathematical that it
took many years before its message was fully understood.
If Gibbs had a fault, it was that he used mathematics to do nearly
all of his talking for him. He felt little need to relate his
mathematics and ideas to real-world examples and he was not
concerned if people said his work was too hard to understand.
Honors
In 1880 Gibbs won the Rumford Prize of the American Academy of
Arts and Sciences.
Click here to go at the top
4

17-07-2015

In 1901 he was awarded the British Royal Societys Copely Medal,

which was then the greatest prize in science, equal to a Nobel
Prize today; and a rarer award, since only one Copely Medal was
awarded each year. The award citation stated that Gibbs was:
the first to apply the second law of thermodynamics to the
exhaustive discussion of the relation between chemical, electrical,
and thermal energy and capacity for external work.
Some Personal Details and the End
Except for three years in Europe, Gibbs lived all his life in the large
family home his father built in New Haven, Connecticut.
This steady life suited him, because he was a man who enjoyed
regularity and order. There is an irony in this, given that Gibbs
significantly advanced our understanding of entropy which is
often characterized as disorder.
He attended church regularly and left New Haven only during his
summer vacations, which he liked to spend in the mountains.
Gibbs was perceived by people who knew him as kind,
sympathetic and happy. He never married. He shared the family
home with his sisters: Anna, who remained unmarried; and Julia,
her husband and children.
Josiah Willard Gibbs died at the age of 64 on April 28, 1903, just a
year after he published his seminal work on statistical
thermodynamics. His death was caused by an intestinal
obstruction.
He was buried in the Grove Street Cemetery, New Haven.

NEWS UPDATE

New
limb-lengthening
technique
is
cumbersome for patients: 17th July, 2015

less

A highly specialized procedure that lengthens bones can prevent

the need for amputations in selected patients who have suffered
severe fractures. And now a new study has found that an
alternative limb-lengthening technique makes the long recovery
Click here to go at the top
5

17-07-2015

process less cumbersome -- while still providing good-to-excellent

outcomes.

Can cholesterol-lowering drugs help treat acute

Ebola cases? : 17th July, 2015

In the course of basic research in membrane biochemistry

scientists have gained new insight into the cytotoxic effect of the
Ebola virus. Employing biochemical and cell biological methods
they have shed light on the molecular relationships between the
Ebola glycoprotein and its role in mediating cytotoxicity.
Researchers discovered that the virus glycoprotein interacts with
cellular cholesterol, thus prompting the use of certain cholesterollowering agents in their investigations. The researchers report they
succeeded in suppressing cellular damage in cell cultures.

Researchers test bioartificial liver device to

treat acute liver failure: 17th July, 2015

Researchers have developed and are testing an alternative to liver

transplantation called the Spheroid Reservoir Bioartificial Liver
that can support healing and regeneration of the injured liver, and
improve outcomes and reduce mortality rates for patients with
acute liver failure.

Dairy
products
boost
probiotics: 17th July, 2015

effectiveness

of

The success of probiotics for boosting human health may depend

partly upon the food, beverage, or other material carrying the
probiotics, according to research.

Cholesterol metabolism in immune cells linked to

HIV progression: 17th July, 2015
Lower levels of cholesterol in certain immune cells -- a result of
enhanced cholesterol metabolism within those cells -- may help
explain why some HIV-infected people are able to naturally
control disease progression, according to research. The findings
provide a basis for potential development of new approaches to
Click here to go at the top
6

17-07-2015

control HIV
metabolism.

infection

by

regulating

cellular

cholesterol

Lymphomas tied to metabolic disruption: 17th

July, 2015

Direct links between disrupted metabolism and an often fatal type

of lymphoma have been uncovered by researchers.

Study in mice may identify new ways to treat

immune thrombocytopenia: 17th July, 2015

A study in mice may identify new ways to treat immune

thrombocytopenia. Immune thrombocytopenia, or ITP, is an
autoimmune disease whereby the immune system sends antibodies
to attack and destroy the body's platelets--blood cells responsible
for controlling bleeding.

Moderate hormone suppression may be enough in

thyroid cancer, 30-year study shows: 17th July,
2015

Moderate suppression of thyroid-stimulating hormone, which

drives thyroid cancer, may be as beneficial as more extreme
hormone suppression, a study of long-term thyroid cancer
outcomes shows. Extreme TSH suppression is associated with
increased side effects including osteoporosis and heart rhythm
irregularities.

Personalized care for aortic aneurysms, based

on gene testing, has arrived: 16th July, 2015

Researchers have tested the genomes of more than 100 patients

with thoracic aortic aneurysms, a potentially lethal condition, and
provided genetically personalized care. Their work will also lead to
the development of a 'dictionary' of genes specific to the disease,
according to researchers.

Click here to go at the top

7

17-07-2015

Emissions have declined, but sulfur dioxide air

pollutant still a concern for asthmatics: 16th
July, 2015
Emissions of the air pollutant sulfur dioxide have been
dramatically decreased during the past 30 years but for some
people even a little inhaled sulfur dioxide may still be too much.
For detail mail to editor

KNOWLEDGE BASED ARTICLE

Miniature brains made from patient skin cells

reveal insights into autism

Understanding diseases like autism and schizophrenia that affect

development of the brain has been challenging due to both the
complexity of the diseases and the difficulty of studying
developmental processes in human tissues. In a study published
July 16 in Cell, researchers have made steps toward overcoming
these challenges by converting skin cells from autism patients into
stem cells and growing them into tiny brains in a dish, revealing
unexpected mechanisms of the disease.
Most autism research has taken the approach of combing through
patient genomes for mutations that may underlie the disorder and
then using animal or cell-based models to study the genes and their
possible roles in brain development. Although this has yielded a
handful of rare disease genes, the limitations of these models and
the complexity of the disorder have frustrated researchers and left
over 80% of autism cases with no clear genetic cause. The new
study now turns the traditional approach on its head.
"Instead of starting from genetics, we've started with the biology of
the disorder itself to try to get a window into the genome," says
senior author Flora Vaccarino the Harris Professor of Child
Psychiatry and Professor or Neurobiology at the Yale School of
Medicine.
Click here to go at the top
8

17-07-2015

The clinical characteristics of autism are complex and wideranging, making the prospect of finding common underlying
factors slim. To stack the deck in their favor, the researchers
focused on the approximately one-fifth of autism patients that
share a distinctive feature correlated with disease severity--an
enlarged brain. After isolating skin cells from these individuals, as
well as their unaffected fathers to provide a point of comparison,
the researchers converted the cells into induced pluripotent stem
cells that were then grown into miniature brains.
These so-called "brain organoids" are just a few millimeters in
diameter but mimic the basics of early human brain development,
roughly corresponding to the first few months of gestation. When
the researchers analyzed the patient organoids, they uncovered
altered expression networks for genes controlling neuronal
development. Patient organoids showed an unexpected
overproduction of inhibitory neurons that quiet down neural
activity, while those that excite the partners they're wired to were
unaffected, leading to an imbalance in neuron type. Remarkably,
by suppressing the expression of a single gene whose expression
was abnormally increased in patient organoids, the authors were
able to correct this bias, suggesting that it may be possible to
intervene clinically to restore neuronal balance.
With current technology, human brain organoids only recapitulate
early stages of development; however, efforts to extend their
growth to later stages are under way by a number of groups and
will allow even further insights into disease mechanisms. The
authors are now using their data to home in on the difficult-to-find
mutations or epigenetic changes responsible for the gene
expression alterations and neuronal imbalance observed in the
study.
According to Vaccarino: "This study speaks to the importance of
using human cells and using them in an assay that could bring a
better understanding of the pathophysiology of autism and with
that, possibly better treatments." The success of the approach also
suggests that similar methods might be used to gain important
Click here to go at the top
9

17-07-2015

insights into other human developmental diseases that have until

now been difficult to crack open.
This work was primarily supported by the National Institutes of
Health, the Harris Professorship fund, The National Institute of
Mental Health, the State of Connecticut, and the Foster-Davis
Foundation Inc. through the Brain and Behavior Research
Foundation.
Jeenatara Begum
Assistant Professor
GNIPST

DISEASE RELATED BREAKING NEWS

Middle East respiratory syndrome coronavirus

(MERS-CoV) Republic of Korea : 17th July,
2015

Situation in the Republic of Korea

Between 15 and 17 July 2015, the National IHR Focal Point of the
Republic of Korea notified WHO of no additional cases of
infection and no new deaths related to Middle East Respiratory
Syndrome Coronavirus (MERS-CoV).
Read more

UPCOMING EVENTS

61 IPSF World Congress sponsored by Indian Pharmaceutical

st

Association (IPA) at Marriott Hotel, Hyderabad, India is going to

th
th
on 30 July to 9 August, 2015.
For further details please visit www.ipsf2015.org

Click here to go at the top

10

17-07-2015

DRUGS UPDATES

Ipsen Announces FDA Approval of Dysport

(abobotulinumtoxinA) for Upper Limb Spasticity:
16th July, 2015
Ipsen (Euronext: IPN; ADR: IPSEY) announced that the U.S. Food
and Drug Administration (FDA) has approved its supplemental
Biologics
License
Application
(sBLA)
for
Dysport
(abobotulinumtoxinA) for the treatment of upper limb spasticity
in adult patients after the submission of the dossier in September
2014. Dysport is now approved for the treatment of upper limb
spasticity in adult patients, to decrease the severity of increased
muscle tone in elbow flexors, wrist flexors and finger flexors.
Clinical improvement may be expected one week after
administration of Dysport. A majority of patients in clinical studies
were retreated between 12 and 16 weeks; some patients had a
duration of response as long as 20 weeks. In Europe, regulatory
procedures are in progress for strengthening the existing upper
limb spasticity label indication of Dysport to include key medical
data such as muscle dose recommendations, treatment intervals,
efficacy data and safety updates.
Read more

CAMPUS NEWS
FAREWELL PROGRAMME:

On 15th May 2015 GNIPST clebrated the farewell programme Sesh

Chithi for the final year students of M.Pharm, M.Sc, B.Pharm, B.Sc
and BHM.
JIS SAMMAN 2015
On 11th May, 2015 GNIPST attended the JIS SAMMAN 2015.
JIS SAMMAN Awards:
Best College (Non Engineering):
GNIPST
Best Principal:
Click here to go at the top
11

17-07-2015

Dr (Prof.) Avijit Sengupta

Best HOD:
Mr. Jaydip Ray
Best Faculty:
Mr. Debabrata Ghoshdastidar (Pharmacy)
Dr. Swati Chakraborty (Life Sciences)
Best faculty since inception:
Mr. Jaydip Ray
Best Office Staff:
Ms. Jaya Banerjee
Best technical Assistant:
Mr. Somnath Majhi
College Blue:
Avik Paul
Highest DGPA of 2014:
B.Pharm:
Purbali Chakraborty (4th year)
Diksha Kumari (3rd year)
Aishika Dutta (2nd year)
Sampita Paul (1st year)
M.Pharm:
Aritra Mukherjee (Pharmaceutical Chemistry)
Mounomukhar Bhattacharya (Pharmacology)
B.Sc (Biotechnology):
Papiya Saha (3rd year)
Shomasree Das (2nd year)
Ayanita Basak (1st year)
B.Sc (Microbiology):
Bonhisikha Chatterjee (3rd year)
Riaz Hossain (2nd year)
Soumi Chowdhury (1st year)
BHM:
Bishal Roy (3rd year)
Shreyabhanja Chowdhury (2nd year)
Click here to go at the top
12

17-07-2015

Recitation:

Udita Majumder
Debate:
Srijita Roy
Poushali Ganguly
Quiz:
Arani
Dipayan Nath
Band:
Syantan Ghoswami
Anurag Ghosh
Atanu Mondal
Arka Khamaru
Ritobroto Paul
Abhirup Dasgupta
Fashion:
Md. Nadeem Shah
Koustav Sarkar
Shaksar Saha
Avirup Dasgupta
Ranit Kundu
Namrata Ganguly
Shreyasee Mitra
Chandrika Saha
Debopriya Chatterjee
Riya Taran
Innovative Modeling:
Ankit Chowdhury
Kartik Koley
Mudasar Manna
Dipan Chaterjee
Abhishek Singh
Kaustav Pal
Manojit Dutta

Ray

Click here to go at the top

13

17-07-2015

SPIRIT JIS 2015

On 03th to 05th April, 2015 JIS organised SPIRIT JIS 2015.

GPAT 2015 Result:
The following B.Pharm. final year students have qualified, GPAT2015. We congratulate them all.
Diksha Kumari
Rupanjay Bhattacharya
Avik Paul
Xtasy 2015:
GNIPST is going to organize the Tech Fest Xtasy 2015 from 30th
March, 2015 to 1st April, 2015.
FINISHING SCHOOL TRAINING PROGRAMME:
The FINISHING SCHOOL TRAINING PROGRAMME is going
to organize by the Entrepreneurship Development Cell and
Training & Placement Cell, GNIPST in collaboration with Indian
Pharmacy Graduates Association (IPGA), Bengal Branch from 21st
February to 11th April, 2015 at GNIPST Auditorium.
st
On 21 February, 2015 the Finishing School Training Programme of
GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy
Director, Drug Control Office, Goutam Kr. Sen, President, IPGA,
Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr.
Ranendra Chakraborty, Sales Manager and Associate Director Dr.
Reddys Laboratory.
On 28th February, 2015 Dr. D. Roy, Former Deputy Drug
Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager,
Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning &
Development, Cipla delivered their valuable lectures in the 2nd day
FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.
On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager,
QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager,
Operation, Ranbaxy Laboratory Limited delivered their valuable
lectures in the 3rd day FINISHING SCHOOL TRAINING
PROGRAMME of GNIPST.

Click here to go at the top

14

17-07-2015

On 21st March, 2015 Mr. Tridib Neogi, Associate Vice-President

(Quality Assurance), Albert David Ltd. delivered his valuable
lectures in the 4th FINISHING SCHOOL TRAINING
PROGRAMME of GNIPST.
On 28th March, 2015 Dr. Gautam Chaterjee, an Alumni of Jadavpur
University and presently associated with NIPER delivered his
valuable lectures in the 5th FINISHING SCHOOL TRAINING
PROGRAMME of GNIPST.
On 11th April, 2015 the closing ceremony of the FINISHING
SCHOOL TRAINING PROGRAMME was held in GNIPST
Auditorium.
JOBS:
All the students of Final Year B. Pharm and M. Pharm are hereby
informed that an interview will be conducted on 23rd May, 2015 by
Standard Pharmaceuticals Ltd. GSK for post: Production, QA, QC.
All the students of Final Year B. Pharm and M. Pharm are hereby
informed that an interview will be conducted by GSK for sales and
marketing job.
Details given below:
Date: 27.03.2015
Time: 09:45 am
Venue : GSK Consumer Healthcare Limited, Unit No. 208,
nd
2 Floor, Ecospace Campus B (3 B), New Town,
Rajarhat, 24 Pgs (N). Kolkata-700156.
THYROCARE provisionally selected 15 students from JIS Group.
Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc
Biotechnology have been selected.
Ipsita Mondal (M. Sc Biotechnology)
Debriti Paul (M. Sc Biotechnology)
Debopriya Chatterjee {B. Sc (H) Biotechnology}
The final year students of B.Pharm (31 students) and B.Sc (11
students) attended the pooled campus drive of Abbott India Ltd.
on 10th March, 2015 at Jadavpur University. Among them 17
students have gone through to the final round of this pooled
campus drive and short listed for final selection.
Click here to go at the top
15

17-07-2015

ACHIEVEMENT:
Congratulations to Anurag Chanda, student of B.Pharm final year
who have got the 1st prize in poster presentation event in Prakriti
2015 at Department of Agricultural and Food engineering, IIT,
Kharagpur.

OTHERS:
On 24 and 25 February, 2015 Swamiji of Gourio Math
th

th

wasdelivered some motivational lectuers in GNIPST.

The students of GNIPST participated in the 4 Sardar Jodh

th

th

SinghTrophy organised by NIT on 20 February, 2015.

On 8th February, 2015 Gnipst celebrated the Reunion
programmeReminiscence Reloaded 2015.

STUDENTS SECTION
WHO CAN ANS WER FIRS T????

Peru,oya and Kuroshio are types of

which geographical phenomenon?
Answer of Previous Issues Questions:
Dopamin

Identify the person

Answer of Previous Issues Image:

Lewis Carroll

Click here to go at the top

16

17-07-2015

Send
your
thoughts/
Quiz/Puzzles/games/write-ups or any other
contributions
for
Students
Section&
answers of this Section at gnipstbulletin@gmail.com

EDITORS NOTE
It is a great pleasure for me to publish the 2nd issue of 47th Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
are able to avail the bulletin through facebook account GNIPST
bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
of GNIPST for his valuable advice and encouragement. Special
thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the
improvement of the bulletin is the contribution of the readers. You
are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
ARCHIVE
The general body meeting of APTI, Bengal Branch has been
conducted at GNIPST on 15th June, 2012. The program started with
a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural
Products, JU on the skill to write a good manuscript for
publication in impact journals. It was followed by nearly two hour
long discussion among more than thirty participants on different
aspects of pharmacy education. Five nonmember participants
applied for membership on that very day.

Click here to go at the top

17

17-07-2015

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm)
in PHARMACOLOGY. The approved number of seat is 18.
The number of seats in B.Pharm. has been increased from 60 to
120.
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.

Activity Clubs of GNIPST:

Name of Club
SPORTS
LITERARY AND PAINTING
SCIENCE AND INNOVATIVE
MODELLING
ECO
SOCIAL SERVICES
PHOTOGRAPHY
CULTURAL
DEBATE AND EXTEMPORE

Member Faculty
Mr. Debabrata GhoshDastidar
Ms. Jeenatara Begum
Mr. Samrat Bose
Ms. Sumana Roy
Dr. Asis Bala
Ms. Sanchari Bhattacharya
Ms. Priyanka Ray
Mr. Soumya Bhattacharya
Click here to go at the top

18